Is Sarepta Therapeutics, Inc. (SRPT) One of the Best Revenue Growth Stocks to Buy According to Analysts?

A recent article analyzes Sarepta Therapeutics, Inc. (NASDAQ: SRPT) against other top revenue growth stocks recommended by analysts. It discusses the impact of recent Fed rate cuts and market trends.